Zhongtai Securities Co.Ltd(600918) the small and medium-sized market research team combs and studies the companies approved by the CSRC to register their initial public offerings in the latest week (November 29, 2021-december 05, 2021) on the gem and the science and innovation board, and launches the weekly special research report on new shares, which will be extended to the corresponding stocks of the Beijing stock exchange in the future. This weekly report involves 1 enterprise on the science and innovation board and 6 enterprises to be issued on the gem:
Kechuang board:
Yahong Pharmaceutical (a21079. SH): the company is a global innovative pharmaceutical company focusing on the field of urogenital tumors and other major diseases. The company has no sales of listed products, no operating revenue and operating costs. The innovative drug industry has a high prosperity. There are no products approved for listing in the fields involved in the company’s two core products worldwide, which has great commercial potential. With the implementation of raised investment projects and the further enhancement of R & D ability and marketing ability, the company’s profitability and market position are expected to be significantly improved after the drug is listed.
Gem:
Jiayuan Technology (a20625. SZ): the company is a provider of comprehensive solutions for information services and network information security, focusing on the fields of national defense and military industry, medical health and government services. From 2017 to 2020, the compound growth rates of revenue and net profit were 34.21% and 68.47% respectively, which were significantly higher than the average of comparable companies. At present, the company has complete qualifications, has established a technology R & D system with strong innovation ability, combines software and hardware, and forms the coverage advantage of the whole industrial chain. It is necessary to continue to pay attention to the R & D Progress of the company’s platform upgrading and technical support projects. After successful R & D, it will promote the company’s existing business to a higher level and comprehensively enhance the company’s comprehensive competitive strength.
Tianyuan environmental protection (a20628. SZ): the company is a comprehensive environmental treatment service provider specializing in the treatment of landfill leachate and difficult sewage and wastewater. It is a national high-tech enterprise. From 2017 to 2020, the compound growth rates of revenue and net profit were 58.39% and 140.56% respectively, which has outstanding advantages compared with the average growth rate of the industry. The company is in an advantageous position in technology research and development, high-quality customers and diversified services, and its comprehensive strength is in the first echelon of the industry. Considering the continuous increase of relevant demand in waste and sewage treatment industry and broad market space, it is expected that the profitability and performance of the company will be further improved with the expansion of production capacity of raised investment projects and the improvement of technical support.
Vico molding (a20618. SZ): the company’s core business is precision injection mold business and extends its business to the production and sales of injection molded parts and health household appliances. It is a typical “molding integration” enterprise in the industry and can provide “one-stop” products and services for customers in downstream industries. From 2017 to 2020, the compound growth rates of revenue and net profit attributable to parent company were 19.67% and 45.81% respectively. At present, the company has rich experience and technology in the R & D, design, manufacturing and sales of precision injection molds, and has a strong competitive advantage. The raised investment project is expected to expand the company’s production capacity of precision injection molds and injection molded parts, improve the company’s technical R & D strength and marketing service ability, and further improve its profitability.
Yike food (a19497. SZ): as a major large-scale leading enterprise of poultry food in China, the company is engaged in poultry slaughtering and processing, feed production and sales, commercial poultry seedling incubation and sales, as well as the production and sales of cooked food and conditioning products. From 2017 to 2020, the compound growth rates of revenue and net profit attributable to parent company were 24.15% and 22.34% respectively. As one of the main meat consumer goods in China, the consumption demand of poultry has maintained a long-term and stable growth trend. The company expands the company’s production capacity through fund-raising, improves the company’s market share, and further enhances the company’s market position and profitability.
Xinghui ring material (a20597. SZ): the company is specialized in polymer synthetic material polystyrene (PS) a high-tech enterprise engaged in R & D, production and sales. The compound growth rates of revenue and net profit from 2017 to 2020 were 1.40% and 60.50% respectively. The polystyrene industry has broad market space, supported by national policies and has import substitution effect. With the implementation of raised investment projects, it helps the company break through the capacity bottleneck, which is expected to further improve the company’s scale and market competitiveness.
Bidding stock (a20609. SZ): the company is a comprehensive engineering consulting service provider specializing in engineering supervision, test and detection, bidding services, surveying and mapping and geographic information services, survey and design and other technical services. From 2017 to 2020, the compound growth rates of revenue and net profit were 12.96% and 0.61% respectively. The development of new infrastructure drives the high prosperity of the engineering consulting industry. The company is a local state-owned enterprise and has an advantage in customer resources. With the implementation and completion of six specific fund-raising and investment projects, the company’s core competitiveness will be significantly improved and continue to consolidate its leading position in the industry.
Risk tips: 1) the corresponding companies still have the risk of failure to be listed due to special events; 2) The research is only based on the prospectus (Registration draft) and other public materials of the corresponding company, which can not fully reflect the latest situation of the company.
